Tirzepatide Research
Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis
Obesity·March 1, 2026
Robert M. Haw, et al.
Summary
Analysis of psychiatric safety outcomes in tirzepatide clinical trials in patients with obesity and no known major psychopathology.
Study Details
Study Design
Post hoc analysis of SURMOUNT trials
Indication
Obesity without major psychopathology
Intervention
Tirzepatide vs placebo
Species
Human